• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

GlaxoSmithKline (GSK) (Group)

GlaxoSmithKline- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. *

 

	Start	2000-12-27 merged
	Predecessor	Glaxo Wellcome (Group)
	Industry	pharmaceutical
	Industry 2	vaccine
	Person	Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal)
	Person 2	Mackay, Iain (GSK 201901– CFO before HSBC + GE + Schlumberger Dowell + Price Waterhouse)
	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	980 Great West Road
	City	TW8 9GS Brentford, Middlesex
	Tel	+44-0-20-8047-5000
		Address record changed: 2008-12-07
Basic data	Employees	n. a.
	Currency	GBP
	Annual sales	22,716,000,000 (turnover, consolidated (2007) 2007-12-31)
	Profit	7,931,000,000 (2007-12-31)
	Cash	3,379,000,000 (2007-12-31)
		* Document for �About Section�:
		Record changed: 2020-10-08

Advertisement

More documents for GlaxoSmithKline (GSK) (Group)

• [1] Nvidia Corporation. (10/5/20). "Press Release: Nvidia Announces Partnership with GSK’s AI-Powered Lab for Discovery of Medicines and Vaccines". Santa Clara, CA....
• [2] BioInnovation Institute (BII). (9/24/20). "Press Release: BioInnovation Institute Partners with Eight International VCs". Copenhagen....
• [3] ELRIG (UK) Ltd.. (9/23/20). "Press Release: ELRIG UK Elects Melanie Leveridge to Lead the Organisation as Chair". York....
• [4] GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 vaccine". London & Paris....
• [5] GlaxoSmithKline plc. (7/31/20). "Press Release: Sanofi and GSK in Advanced Discussions with European Union to Supply up to 300 Million Doses of COVID-19 Vaccine". London & Paris....
• [6] CureVac AG. (7/21/20). "Press Release: CureVac Raises a Total of USD 640 Million in Private Financing Round". Tübingen....
• [7] CureVac AG. (7/20/20). "Press Release: GSK and CureVac Announce Strategic mRNA Technology Collaboration"....
• [8] GlaxoSmithKline plc. (6/16/20). "Press Release: Ideaya and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology". South San Francisco, CA & London....
• [9] Immatics Biotechnologies GmbH. (6/4/20). "Press Release: Immatics Appoints Cedrik Britten as Chief Medical Officer". Houston, TX & Tübingen....
• [10] GlaxoSmithKline plc. (5/21/20). "Press Release: GSK Partners with Samsung Biologics to Secure Additional Manufacturing Capacity for Innovative Biopharmaceutical Portfolio". London & Songdo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.